Correlation Between Acumen Pharmaceuticals and Chemours

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Chemours at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Chemours into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Chemours Co, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Chemours and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Chemours. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Chemours.

Diversification Opportunities for Acumen Pharmaceuticals and Chemours

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Acumen and Chemours is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Chemours Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chemours and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Chemours. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chemours has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Chemours go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Chemours

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Chemours. In addition to that, Acumen Pharmaceuticals is 1.31 times more volatile than Chemours Co. It trades about -0.18 of its total potential returns per unit of risk. Chemours Co is currently generating about 0.24 per unit of volatility. If you would invest  1,793  in Chemours Co on September 1, 2024 and sell it today you would earn a total of  381.00  from holding Chemours Co or generate 21.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Acumen Pharmaceuticals  vs.  Chemours Co

 Performance 
       Timeline  
Acumen Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Acumen Pharmaceuticals is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Chemours 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Chemours Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile fundamental indicators, Chemours exhibited solid returns over the last few months and may actually be approaching a breakup point.

Acumen Pharmaceuticals and Chemours Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acumen Pharmaceuticals and Chemours

The main advantage of trading using opposite Acumen Pharmaceuticals and Chemours positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Chemours can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will offset losses from the drop in Chemours' long position.
The idea behind Acumen Pharmaceuticals and Chemours Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
CEOs Directory
Screen CEOs from public companies around the world